Search results
Results from the WOW.Com Content Network
Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer. [12] [14] [15] [16] It is administered by slow intravenous ...
In the United States, dostarlimab costs around US$11,000 per dose. [44] Among those who are insured, those who have Medicaid insurance are less likely to receive full care for gynecologic cancer. [45] Those insured through private insurance still experience economical hardships while getting treatment. [45]
Keytruda, approved for several types of cancer, alone accounts for more than 25% of Merck's (MRK) pharmaceutical sales Animal health and vaccine products remain core growth drivers.
Keytruda sales rose 21% to $6.6 billion as the company was able to increase use of the drug in earlier stage cancers, topping analyst forecasts of $6.5 billion.
The results come at a median point of three years into the study involving 157 patients with stage III/IV melanoma whose tumors were surgically removed before being treated with either the drug ...
During pregnancy, women of an average pre-pregnancy weight (BMI 18.5-24.9) should expect to gain between 25–35 pounds (11–16 kg) over the course of the pregnancy. [32] Increased rates of hypertension, diabetes, respiratory complications, and infections are prevalent in cases of maternal obesity and can have detrimental effects on pregnancy ...
The U.S. health regulator's approval extends Keytruda's use in combination with chemotherapy as a treatment given before surgery to shrink the size of the tumor in patients. The U.S. drugmaker is ...
The study determined that the risk of stillbirth per 1000 births after 40, 41 and 42 weeks of gestation were 0.42, 0.61 and 1.08, respectively. [21] Thus, it is important to acknowledge the probabilistic evidence when discussing formal medical inductions, because it highlights the how small the likelihood of having a stillbirth post-term is.